Michael Stirm

Pig models for Duchenne muscular dystrophy – from disease mechanisms to validation of new diagnostic and therapeutic concepts

R. Wanke, H. Blum, W. Wurst, 2022, Neuromuscular Disorders.

Pig models for Duchenne muscular dystrophy – from disease mechanisms to validation of new diagnostic and therapeutic concepts

R. Wanke, H. Blum, W. Wurst, 2022, Neuromuscular Disorders.

A scalable, clinically severe pig model for Duchenne muscular dystrophy

R. Wanke, S. Ziegler, C. Bearzi, 2021, bioRxiv.

A scalable, clinically severe pig model for Duchenne muscular dystrophy.

R. Wanke, S. Ziegler, C. Bearzi, 2021, Disease models & mechanisms.

Increased pulmonary monocyte infiltration and attenuated phagocytosis defines perinatal dysfunction of innate immunity in Cystic Fibrosis

H. Blum, K. Kunzelmann, K. Laugwitz, 2023, bioRxiv.

Pig models for translational Duchenne muscular dystrophy research.

E. Wolf, Michael Stirm, Eckhard Wolf, 2024, Trends in molecular medicine.

Phenotypic features of genetically modified DMD-XKOXWT pigs

N. Klymiuk, M. Kurome, H. Nagashima, 2023, Regenerative therapy.

Systemic deletion of DMD exon 51 rescues clinically severe Duchenne muscular dystrophy in a pig model lacking DMD exon 52

W. Wurst, V. Zakhartchenko, T. Fröhlich, 2023, Proceedings of the National Academy of Sciences of the United States of America.